Insider Trading: Isis Pharmaceuticals Inc (ISIS.O)
ISIS.O on Nasdaq
20.98USD
24 May 2013
20.98USD
24 May 2013
Price Change (% chg)
$0.34 (+1.65%)
$0.34 (+1.65%)
Prev Close
$20.64
$20.64
Open
$20.55
$20.55
Day's High
$21.07
$21.07
Day's Low
$20.43
$20.43
Volume
878,047
878,047
Avg. Vol
1,621,097
1,621,097
52-wk High
$23.03
$23.03
52-wk Low
$7.55
$7.55
All Insider Trades
| Trading Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| 30 Apr 2013 | BENNETT C FRANK |
Officer | Sell | 23,800 | $22.26 |
| 30 Apr 2013 | BENNETT C FRANK |
Officer | Buy | 6,145 | $11.12 |
| 30 Apr 2013 | BENNETT C FRANK |
Officer | Buy | 23,800 | $6.81 |
| 30 Apr 2013 | BENNETT C FRANK |
Officer | Sell | 6,145 | $22.26 |
| 29 Apr 2013 | BENNETT C FRANK |
Officer | Sell | 30,000 | $22.51 |
| 29 Apr 2013 | BENNETT C FRANK |
Officer | Buy | 30,000 | $11.12 |
| 24 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Buy | 7,454 | $11.12 |
| 24 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Sell | 18,400 | $22.50 |
| 24 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Buy | 18,400 | $6.81 |
| 24 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Sell | 7,454 | $22.50 |
| 23 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Buy | 30,000 | $11.12 |
| 23 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Sell | 30,000 | $22.12 |
| 23 Apr 2013 | HOUGEN ELIZABETH L |
Chief Financial Officer | Sell | 10,417 | $22.38 |
| 23 Apr 2013 | CROOKE STANLEY T |
Chief Executive Officer | Sell | 10,000 | $22.12 |
| 23 Apr 2013 | HOUGEN ELIZABETH L |
Chief Financial Officer | Buy | 10,417 | $15.38 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Sell | 3,900 | $22.13 |
| 22 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Buy | 10,000 | $6.81 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Buy | 1,800 | $8.00 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Sell | 2,700 | $22.13 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Sell | 1,800 | $22.13 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Buy | 3,900 | $10.29 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Buy | 2,260 | $14.47 |
| 22 Apr 2013 | PARSHALL B LYNNE |
Chief Operating Officer | Sell | 10,000 | $22.10 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Buy | 2,700 | $11.27 |
| 22 Apr 2013 | O NEIL PATRICK R |
General Counsel | Buy | 6,000 | $15.38 |
Institutional Holders
| % Shares Owned: | 78.34% |
| # of Holders: | 216 |
| Total Shares Held: | 87,506,080 |
| 3 Mo. Net Change: | 6,527,365 |
| # New Positions: | 51 |
| # Closed Positions: | 19 |
| # Increased Positions: | 102 |
| # Reduced Positions: | 85 |
| # Net Buyers: | 17 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Stanley Crooke |
67 | 1991 | Chairman of the Board, President, Chief Executive Officer |
Elizabeth Hougen |
51 | 2013 | Chief Financial Officer, Senior Vice President - Finance |
B. Lynne Parshall |
58 | 2013 | Chief Operating Officer, Corporate Secretary, Director |
Patrick O'Neil |
39 | 2013 | Senior Vice President - Legal, General Counsel |
C. Frank Bennett |
56 | 2006 | Senior Vice President - Antisense Research |
Richard Geary |
55 | 2008 | Senior Vice President - Development |
Brett Monia |
51 | 2012 | Senior Vice President - Drug Discovery and Corporate Development |
Spencer Berthelsen |
60 | 2002 | Independent Director |
Joseph Klein |
51 | 2005 | Independent Director |
Frederick Muto |
2001 | Independent Director | |
Joseph Wender |
67 | 1994 | Independent Director |
Wade Walke |
Executive Director - Corporate Communications |

